Correlation Between Smith Nephew and CochLear
Can any of the company-specific risk be diversified away by investing in both Smith Nephew and CochLear at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smith Nephew and CochLear into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smith Nephew SNATS and CochLear Ltd ADR, you can compare the effects of market volatilities on Smith Nephew and CochLear and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smith Nephew with a short position of CochLear. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smith Nephew and CochLear.
Diversification Opportunities for Smith Nephew and CochLear
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Smith and CochLear is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and CochLear Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CochLear ADR and Smith Nephew is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smith Nephew SNATS are associated (or correlated) with CochLear. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CochLear ADR has no effect on the direction of Smith Nephew i.e., Smith Nephew and CochLear go up and down completely randomly.
Pair Corralation between Smith Nephew and CochLear
Considering the 90-day investment horizon Smith Nephew SNATS is expected to generate 0.68 times more return on investment than CochLear. However, Smith Nephew SNATS is 1.48 times less risky than CochLear. It trades about 0.06 of its potential returns per unit of risk. CochLear Ltd ADR is currently generating about -0.05 per unit of risk. If you would invest 2,511 in Smith Nephew SNATS on January 28, 2025 and sell it today you would earn a total of 159.00 from holding Smith Nephew SNATS or generate 6.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Smith Nephew SNATS vs. CochLear Ltd ADR
Performance |
Timeline |
Smith Nephew SNATS |
CochLear ADR |
Smith Nephew and CochLear Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Smith Nephew and CochLear
The main advantage of trading using opposite Smith Nephew and CochLear positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smith Nephew position performs unexpectedly, CochLear can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CochLear will offset losses from the drop in CochLear's long position.Smith Nephew vs. CochLear Ltd ADR | Smith Nephew vs. Integer Holdings Corp | Smith Nephew vs. Orthofix Medical | Smith Nephew vs. Glaukos Corp |
CochLear vs. Modular Medical | CochLear vs. Neuropace | CochLear vs. Nexalin Technology | CochLear vs. STRATA Skin Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |